UCL cancer researcher wins international prize for translational medicine
Professor Charles Swanton (UCL Cancer Institute) has been awarded the prestigious Louis-Jeantet Prize 2024 for Translational Medicine for his ground-breaking discoveries in cancer genetics and evolution. Established in 1986, the Louis-Jeantet Prizes annually recognise leading scientific researchers based within Council of Europe member states for outstanding work in the field of biomedical research. Professor Charles Swanton will be awarded the Jeantet-Collen Prize for Translational Medicine, an award with particular focus on research close to practical application in combating illnesses affecting humankind. With 90% of the prize value intended to fund the continuation of the winners' research, the prize comes as a big boost to Professor Swanton's research in cancer genetics and evolution, which is leading to new insights into how tumours evolve, spread, and develop resistance to drugs. Throughout his career, Professor Swanton has changed the way the world understands cancer by demonstrating the disease as an evolutionary process. As Chair of Personalised Medicine at UCL and group leader at the UCL Cancer Institute and the Francis Crick Institute, as well as chief clinician at Cancer Research UK and consultant at UCLH, Professor Swanton continues to be a pioneering force in the field of cancer research. On receiving the news, Professor Swanton said: "I am delighted to have been awarded this prestigious prize.
